Registro:

Referencias:

• Pós, Z., Sáfrány, G., Müller, K., Tóth, S., Falus, A., Hegyesi, H., Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and Rho-c as histamine-regulated melanoma progression markers (2005) Cancer Res, 65, pp. 4458-4466
• De Esch, J.P., Thurmond, R.L., Jongejan, A., Leurs, R., The histamine H4 receptor as a new therapeutic target for inflammation (2005) Trends Pharmacol Sci, 26, pp. 462-469
• Xie, H., He, S.H., Roles of histamine and its receptors in allergic and inflammatory bowel diseases (2005) World J Gastroenterol, 11, pp. 2851-2857
• Medina, V.A., Rivera, E.S., Histamine receptors and cancer pharmacology (2010) Br J Pharmacol, 161 (4), pp. 755-767
• Hegyesi, H., Horváth, B., Pállinger, E., Pós, Z., Molnár, V., Falus, A., Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor (2005) FEBS Lett, 579, pp. 2475-2479
• Lázár-Molnár, E., Hegyesi, H., Pállinger, E., Kovács, P., Tóth, S., Fitzsimons, C., Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6 (2002) Eur J Clin Invest, 32 (10), pp. 743-749
• Szincsák, N., Hegyesi, H., Hunyadi, J., Martin, G., Lázár-Molnár, E., Kovács, P., Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line (2002) Melanoma Res, 12 (3), pp. 231-240
• Tomita, K., Nakamura, E., Okabe, S., Histamine regulates growth of malignant melanoma implants via H2 receptors in mice (2005) Inflammopharmacology, 13, pp. 281-289
• Uçar, K., The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture (1991) Biochem Biophys Res Commun, 177, pp. 545-550
• Blaya, B., Nicolau, G.F., Jangi, S.M., Ortega, M.I., Alonso, T.E., Burgos-Bretones, J., Histamine and histamine receptor antagonists in cancer biology (2010) Inflamm Allergy Drug Targets, 9 (3), pp. 146-157
• Medina, V., Cricco, G., Nuñez, M., Martín, G., Mohamad, N., Correa-Fiz, F., Histamine-mediated signaling processes in human malignant mammary cells (2006) Cancer Biol Ther, 5, pp. 1462-1471
• Zampeli, E., Tiligada, E., The role of histamine H4 receptor in immune and inflammatory disorders (2009) Br J Pharmacol, 157, pp. 24-33
• van Rijn, R.M., Chazot, P.L., Shenton, F.C., Sansuk, K., Bakker, R.A., Leurs, R., Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors (2006) Mol Pharmacol, 70, pp. 604-615
• van Rijn, R.M., van Marle, A., Chazot, P.L., Langemeijer, E., Qin, Y., Shenton, F.C., Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor (2008) Biochem J, 414, pp. 121-131
• Nakamura, T., Itadani, H., Hidaka, Y., Ohta, M., Tanaka, K., Molecular cloning and characterization of a new human histamine receptor, H4R (2000) Biochem Biophys Res Commun, 279, pp. 615-620
• Oda, T., Morikawa, N., Saito, Y., Masuho, Y., Matsumoto, S., Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes (2000) J Biol Chem, 275, pp. 36781-36786
• Hofstra, C.L., Desai, P.J., Thurmond, R.L., Fung-Leung, W.P., Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells (2003) J Pharmacol Exp Ther, 305 (3), pp. 1212-1221
• Kenakin, T., Ligand-selective receptor conformations revisited: the promise and the problem (2003) Trends Pharmacol Sci, 24, pp. 346-354
• Cagnol, S., Chambard, J.C., ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence (2010) FEBS J, 277 (1), pp. 2-21
• Lopez-Bergami, P., The role of mitogen- and stress-activated protein kinase pathways in melanoma (2011) Pigment Cell Melanoma Res, 24 (5), pp. 902-921
• Massari, N.A., Medina, V.A., Martinel Lamas, D.J., Cricco, G.P., Croci, M., Sambuco, L., Role of H4 receptor in histamine-mediated responses in human melanoma (2011) Melanoma Res, 21 (5), pp. 395-404
• Buckland, K.F., Williams, T.J., Conroy, D.M., Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor (2003) Br J Pharmacol, 140, pp. 1117-1127
• Liu, C., Wilson, S.J., Kuei, C., Lovenberg, T.W., Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation (2001) J Pharmacol Exp Ther, 299, pp. 121-130
• Liu, C., Ma, X.J., Jiang, X., Wilson, S.J., Hofstra, C.L., Blevitt, J., Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow (2001) Mol Pharmacol, 59, pp. 420-426
• Zhu, Y., Michalovich, D., Wu, H.L., Tan, K.B., Dytko, G.M., Mannan, I.J., Cloning, expression and pharmacological characterization of a novel human histamine receptor (2001) Mol Pharmacol, 59, pp. 434-441
• Kobayashi, H., Man, S., MacDougall, J.R., Graham, C.H., Lu, C., Kerbel, R.S., Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype (1994) Am J Pathol, 144 (4), pp. 776-786
• Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., A biomarker that identifies senescent human cells in culture and in aging skin in vivo (1995) Proc Natl Acad Sci USA, 92 (20), pp. 9363-9367
• Medina, V.A., Brenzoni, P.G., Martinel Lamas, D.J., Massari, N., Mondillo, C., Nuñez, M.A., Role of histamine H4 receptor in breast cancer cell proliferation (2011) Front Biosci (Elite Ed), 3, pp. 1042-1060
• Mondillo, C., Patrignani, Z., Reche, C., Rivera, E., Pignataro, O., Dual role of histamine in modulation of Leydig cell steroidogenesis via HRH1 and HRH2 receptor subtypes (2005) Biol Reprod, 73 (5), pp. 899-907
• Bayne, K., Revised guide for the care and use of laboratory animals available (1996) Am Physiol Soc Physiol, 39 (4), pp. 208-211. , 199
• Lázár-Molnár, E., Cricco, G., Martin, G., Darvas, Z., Hegyesi, H., Fitzsimons, C., Histamine as a potential autocrine regulator of melanoma (2001) Inflamm Res, 50, pp. S102-S103
• Canton, H., Verrièle, L., Colpaert, F.C., Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites (1990) Eur J Pharmacol, 191 (1), pp. 93-96
• Ellenbroek, B.A., Artz, M.T., Cools, A.R., The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine (1991) Eur J Pharmacol, 196 (1), pp. 103-108
• Böni, R., Lichtensteiger, W., Steinert, H.C., Böni, R.A., Früh, H., Dummer, R., D1 dopamine receptors are not expressed in human melanoma (1997) Melanoma Res, 7 (2), pp. 117-119
• Böni, R., Steinert, H., Böni, R.A., Lichtensteiger, W., Dummer, R., Hartman, D.S., Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin (1996) Dermatology, 193 (3), pp. 198-202
• Slominski, A., Pisarchik, A., Zbytek, B., Tobin, D.J., Kauser, S., Wortsman, J., Functional activity of serotoninergic and melatoninergic systems expressed in the skin (2003) J Cell Physiol, 196 (1), pp. 144-153
• Adachi, N., Liu, K., Motoki, A., Nishibori, M., Arai, T., Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats (2006) Eur J Pharmacol, 544 (1-3), pp. 181-187
• Fang, Z., Yao, W., Xiong, Y., Li, J., Liu, L., Shi, L., Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression (2011) BMC Cancer, 11 (195), pp. 1-11
• Sugata, Y., Okano, M., Fujiwara, T., Matsumoto, R., Hattori, H., Yamamoto, M., Histamine H4 receptor agonists have more activities than H4 agonism in antigen-specific human T-cell responses (2013) Immunology, 121 (2), pp. 266-275
• Tanda, S., Mori, Y., Kimura, T., Sonomura, K., Kusaba, T., Kishimoto, N., Histamine ameliorates anti-glomerular basement membrane antibody-induced glomerulonephritis in rats (2007) Kidney Int, 72 (5), pp. 608-613
• Leurs, R., Chazot, P.L., Shenton, F.C., Lim, H.D., de Esch, I.J., Molecular and biochemical pharmacology of the histamine H4 receptor (2009) Br J Pharmacol, 157 (1), pp. 14-23
• Roninson, I.B., Tumor cell senescence in cancer treatment (2003) Cancer Res, 63, pp. 2705-2715
• Medina, V., Croci, M., Crescenti, E., Mohamad, N., Sanchez-Jiménez, F., Massari, N., The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment (2008) Cancer Biol Ther, 7, pp. 28-35
• Petit-Bertron, A.F., Machavoine, F., Defresne, M.P., Gillard, M., Chatelain, P., Mistry, P., H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells (2009) PLoS ONE, 4 (8), p. 6504
• Gbahou, F., Vincent, L., Humbert-Claude, M., Tardivel-Lacombe, J., Chabret, C., Arrang, J.M., Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives (2006) Br J Pharmacol, 147, pp. 744-754
• Morse, K.L., Behan, J., Laz, T.M., West, R.E., Greenfeder, S.A., Anthes, J.C., Cloning and characterization of a novel human histamine receptor (2001) J Pharmacol Exp Ther, 296, pp. 1058-1066
• Lu, Z., Xu, S., ERK1/2 MAP kinases in cell survival and apoptosis (2006) IUBMB Life, 58 (11), pp. 621-631
• Murphy, L.O., Blenis, J., MAPK signal specificity: the right place at the right time (2006) Trends Biochem Sci, 31, pp. 268-275
• Rosethorne, E.M., Charlton, S.J., Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins (2011) Mol Pharmacol, 79 (4), pp. 749-757
• Martinel Lamas, D., Croci, M., Carabajal, E., Crescenti, E.J.V., Sambuco, L., Massari, N.A., Therapeutic potential of histamine H4 receptor agonists in triple-negative human breast cancer experimental model (2013) Br J Phamacol, 170 (1), pp. 188-199
• Darvas, Z., Sakurai, E., Schwelberger, H.G., Hegyesi, H., Rivera, E., Othsu, H., Autonomous histamine metabolism in human melanoma cells (2003) Melanoma Res, 13, pp. 239-246
• Agarwala, S.S., Glaspy, J., O'Day, S.J., Mitchell, M., Gutheil, J., Whitman, E., Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma (2002) J Clin Oncol, 20 (1), pp. 125-133
• Balch, C.M., Gershenwald, J.E., Soong, S.J., Thompson, J.F., Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate (2013) J Surg Oncol, 104 (4), pp. 379-385
• Johansson, M., Henriksson, R., Bergenheim, A.T., Koskinen, L.O., Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma (2000) Br J Cancer, 83 (6), pp. 826-832
• Opgen-Rhein, C., Dettling, M., Clozapine-induced agranulocytosis and its genetic determinants (2008) Pharmacogenomics, 9 (8), pp. 1101-1111

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------